A method for enzymatic preparation of 3-dehydroquinate and 3-dehydroshikimate in the shikimate pathway was established by controlling the enzyme activity of 3-dehydroquinate dehydratase. When quinate was incubated with the membrane fraction of acetic acid bacteria at pH 5.0, 3-dehydroquinate was formed as the predominant product. 3-Dehydroshikimate was the sole product when incubated at pH 8.0. Mutual separation of the metabolic intermediates was also exemplified.
Shikimate (SKA) is a key important metabolic intermediate in the SKA pathway and is known as the direct precursor in the biosynthesis of aromatic amino acids and pharmaceuticals, including more than 10 different antibiotics. Recently, the importance of SKA production has been established, because it is the direct precursor in oseltamivir synthesis, protecting people from global pandemic flu infection, including avian flu. Since we reported a convenient preparation for 3-dehydroquinate (DQA) and 3-dehydroshikimate (DSA) by oxidative fermentation with acetic acid bacteria, 1) we have been responsible for supplying the two compounds to many scientists due to unavailability from commercial sources. At their request, we have provided our products for free, though only on a laboratory scale. In this situation, a standard method for the preparation and isolation of the respective metabolic intermediates in the SKA pathway is significant. Our previous paper reported that quinate (QA) was converted to DSA via DQA by the action of quinoprotein QA dehydrogenase (QDH, EC 1.1.99.25) and DQA dehydratase (DQD, EC 4.1.2.10), localized in the cytoplasmic membrane of acetic acid bacteria.
1) Recently, we have confirmed that DSA thus prepared is reduced to SKA with cytosolic NADPdependent SKA dehydrogenase (SKDH, EC 1.1.1.25) from the same organism when coupled with a suitable NADPH regenerating system such as NADP-dependent D-glucose dehydrogenase (GDH) in the presence of excess D-glucose. 2) In spite of the metabolic significance of the respective metabolic intermediates in the SKA pathway, separation and identification by paper chromatography is the sole available method, as described by Yoshida and Hasegawa.
3) No reliable and useful method for separation by means of column chromatography has been reported. One reason is that DQA and DSA are commercially unavailable, though they are important in a wide variety of biosciences as well as the pharmaceutical industry. In this paper, a method of enzymatic preparation of DQA and DSA along with column chromatographic conditions pertaining to the four metabolic intermediates in the SKA pathway, QA, DQA, DSA, and SKA, is briefly reported. Detection of these four metabolic intermediates was done enzymatically.
The membrane fraction carrying QDH was prepared from cells of Gluconobacter oxydans IFO 3244, as reported previously. 1, 4) The SKDH used was a purified enzyme from G. oxydans IFO 3244, the specific activity of which in SKA oxidation was 178.5 units/mg. 5) DQD was purified from G. oxydans IFO 3244 according to the purification method for Escherichia coli.
6) QA was measured with QDH in the presence of potassium ferricyanide as the electron acceptor, as described previously. 4) Initial velocity measurement was used for the qualitative assay. For the quantitative assay, the end point measurement was employed under similar conditions, as with other cases. [7] [8] [9] Measurement of DQA was done by converting it to DSA under incubation with 0.02 unit of DQD in 1 ml of reaction mixture of 0.1 M Tris-HCl, pH 8.0. Incubation was continued until the increase in absorbance at 234 nm came to equilibrium, and the molecular extinction coefficient of DSA, 1:2 Â 10 4 literÁmol À1 Ácm À1 , was used. 6) SKA and DSA were measured with SKDH in the presence of NADP and NADPH respectively, under conditions similar to those reported previously. 2, 5) The reaction mixture (1 ml) In preliminary conditioning for chromatographic separation of the four intermediates in the SKA pathway with a Dowex 1 Â 4 column, the purity of all compounds used was more than 90%. They were applied one by one at an approximate concentration of 1 mM, and development of the Dowex column (1 Â 10 cm, acetate form) was done under the same conditions. After washing with water at 50 times the column volume, a linear gradient elution between water (200 ml) and 25 mM NaCl (200 ml) was done and fractionated at every 190 drops (about 5.0 ml). QA, SKA, DQA, and DSA appeared at NaCl concentrations of 12 mM, 15 mM, 17 mM and 20 mM respectively. Based on these results, there were differences in affinity and interaction to the Dowex column among the four compounds, although separation of the mixture containing the four compounds is difficult, unless the column size is expanded. Chromatographic separation of the four intermediates at once was done stepwise using a single solution, as in the case of amino acid analysis as developed by Moore and Stein.
10) The column size was changed to a longer one, 0:8 Â 70 cm, and 1 ml of a mixture involving the four compounds (3 mg of each) was applied. When elution was done with 50 mM NaCl and fractionated at every 95 drops (about 2.5 ml), sequential elution, in the order QA, SKA, DQA, DSA, gave better separation than the previous data. Based on our experiences in preparing DQA and DSA by means of oxidative fermentation, it is unusual to see the four intermediate compounds at once in the same culture medium or reaction mixture, because QA, DQA, and DSA are compounds associated with enzyme activities occurring on the outer surface of the cytoplasmic membrane, whereas SKA is a typical cytoplasmic compound found only in the cytoplasm. When separation of DQA or DSA from QA is required, QA is exhausted and becomes almost undetectable (see Fig. 1 ). In the separation of DSA from DQA, DQA is diminished and converted to DSA by incubating the solution with DQD before applying it to a Dowex column. Likewise, in the separation of SKA from DSA, DSA is diminished and converted to SKA, as reported previously. C for 19 h with shaking. Since DQD does not work at pH 5.0, DQA accumulated and remained stable as the major product, reaching 8.4 mg/ml (44.2 mmol/ml) of the reaction mixture. Hence, the conversion rate from QA to DQA was estimated to be 85%. The deproteinized supernatant (0.5 ml containing 4.1 mg, 21.5 mmol, DQA) was diluted to 200 ml, and the pH was adjusted to 6.6 before application to a Dowex 1 Â 4 column (1 Â 10 cm, acetate form), and then developed by a linear gradient using 300 ml each of 5 mM to 25 mM NaCl. A fraction of every 5 ml (190 drops = 5.0 ml/tube) was collected. DQA was measured as the major reaction product exclusive of others, as shown in Fig. 1 . Regarding the nature of the small absorption appearing at fraction numbers 50 to 60, it is unknown, except that it did not react with SKDH, indicating that it was apparently neither DSA nor SKA.
For DSA preparation, dried membrane of G. oxydans IFO 3244 (5 g) was incubated with 1 g (5.2 mmol) of QA in 100 ml of McIlvaine buffer, pH 8.0, at 30 C for 15 h with shaking. Since DQD works optimally at pH 8.0, DQA, an oxidation product of QA, was immediately converted to DSA without remaining as DQA in the reaction mixture. The final conversion rate from QA to DSA was measured to be more than 90%. An aliquot of the deproteinized supernatant (0.5 ml, containing 4.1 mg, 23.4 mmol, DSA) was diluted to 200 ml, and the pH was adjusted to 6.6 before applying it to the same Dowex column. The column was developed by a linear gradient up to 25 mM NaCl (200 ml of water and 200 ml of 25 mM NaCl), and a fraction of every 5 ml (190 drops = 5.0 ml/ tube) was collected. As expected, a sole sharp peak of DSA appeared in the chromatogram, as shown in Fig. 2 . The column was developed by a linear gradient using 300 ml each of 5 mM to 25 mM NaCl. The elution was traced by reading absorbance at 234 nm ( ). DQA ( ) was measured with 0.02 unit of DQD by end-point measurement until the increase in absorbance at 234 nm came to equilibrium. Since QA was oxidized almost completely, only a trace of QA was detected, as shown by a short horizontal bar. The arrowhead means the position of elution for DSA.
Successful enzymatic preparation of DQA and DSA is based on the fact that DQD does not work at pH 5.0, but is optimally active at pH 8.0 (Adachi et al., unpublished observations). Based on the results above, a scale-up the preparation of DQA and DSA presents no problems. One simply increases the reaction volume for QA oxidation and the column size for chromatographic separation. We are able to provide our preparations on request to those who need them until a pharmaceutical firm places them on the market. The column was developed by a linear gradient made with 200 ml of water and 200 ml of 25 mM NaCl. Elution was followed by reading the absorbance at 234 nm ( ). DSA ( ) contents were quantified with SKDH by end-point measurement using 0.1 unit of SKA reduction activity. Arrowheads mean the positions of elution for QA, DQA, and SKA.
